(HealthDay)—The rates of inferior vena cava (IVC) filter placement increased from 2005 until 2010 and then decreased through 2014, according to a research letter published online Nov. 6 in JAMA ...

Inferior vena cava (IVC) filter placement and retrieval procedures have markedly declined over the last decade from previous large growth in Medicare beneficiaries, according to a new Harvey L. Neiman ...

FAIRFAX, Va.—Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters—devices used to keep ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

Prophylactic inferior vena cava filter placement declined in the United States from 2005 to 2014, but rates varied by geography, according to a research letter published in JAMA Internal Medicine. The ...

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava filters -- devices used to keep blood clots from ...

Inferior vena cava (IVC) filter placement and retrieval procedures have markedly declined over the last decade from previous large growth in Medicare beneficiaries, according to a new Harvey L. Neiman ...

Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...

Effect of tolfenamic acid on ovarian cancer cell growth, targeting of specificity protein transcription factors, and expression of c-Met and survivin. Background: Venous thrombosis is a frequent ...

The patient with both recent bleeding and thrombotic events poses a great challenge to clinicians. The rationale for an IVC filter is that it would potentially reduce the risk of morbid or fatal ...

Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained. Of 182 patients, 103 were men and 79 were women. Median age was 59 years (range, 15 to 88 ...